- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Global University Venturing
Analysis: Rivian drives a $2.65bn round
Before the commercial release of Rivians’ electric vehicles (EV) this year, Amazon has returned to back the company in a round valuing it at $27.6bn. The EV space is among the hottest in the automotive business and valuations have remained high despite the cyclical nature of demand for vehicles.
Jan 25, 2021Vera wraps up $80m series C
Yale-linked Vera has rebranded from Trucode Gene Repair and will use the money to move towards clinical trials.
Jan 22, 2021Daily deal net: January 22, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Jan 22, 2021Better Collective bets on Mindway AI
Founded out of Aarhus University in 2004, Mindway AI builds artificial intelligence-driven tools to prevent problem gambling.
Jan 22, 2021NexImmune elects to launch initial public offering
Johns Hopkins University's oncology therapy developer NexImmune has filed to raise up to $86.3m in an IPO on the Nasdaq Global Market.
Jan 21, 2021Bolt Biotherapeutics charges to IPO stage
Novo and Pfizer are among the investors set to exit the Stanford spinout, which has set a $100m target for its initial public offering.
Jan 21, 2021Remynd boosts series B
The KU Leuven spinout has completed another tranche of funding for its series B round featuring investments from the university.
Jan 21, 2021OUI provides fourth quarter update
Oxford spinouts took in $350m in Q4 and OUI saw strong demand for its consulting services on the back of its covid-19 vaccine success.
Jan 21, 2021Vor Biopharma goes for $150m in IPO
Columbia University is in line for an exit as cancer drug developer Vor files for its initial public offering.
Jan 20, 2021Verve Therapeutics turns to $94m series B
Novo and GV participated in a round that lifted the Harvard, Broad Institute and Penn-linked heart disease drug developer's overall funding to more than $215m.
Jan 20, 2021Immunocore plots course to $100m IPO
The immunotherapy developer plans to go public in the US having raised $565m since being formed to develop assets of a defunct Oxford spinout.
Jan 20, 2021Karslake slides into UChicago’s Polsky Center
Christine Karslake is set to lead UChicago’s Polsky Science Ventures unit and will be tasked with setting up a deep tech-focused accelerator.
Jan 20, 2021Featured Content
University Venture Funds: The ListThe definitive list of university venture funds around the worldUniversity Venture Funds: The List
The definitive list of university venture funds around the world
Special ReportCorporate collaboration with universities: How to commercialise innovative researchSpecial Report
Corporate collaboration with universities: How to commercialise innovative research
Beyond the Breakthrough PodcastExplore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?Beyond the Breakthrough Podcast
Explore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
